Updated phase 1 results of teclistamab, a B-cell maturation antigen (BCMA) x CD3 bispecific antibody, in relapsed/refractory multiple myeloma (MM).

被引：12

作者：

Krishnan, Amrita Y.

Garfall, Alfred L.

Mateos, Maria-Victoria

van de Donk, Niels W. C. J.

Nahi, Hareth

San-Miguel, Jesus F.

Oriol, Albert

Rosinol, Laura

Chari, Ajai

Bhutani, Manisha

Karlin, Lionel

Benboubker, Lotfi

Pei, Lixia

Verona, Raluca

Girgis, Suzette

Stephenson, Tara

Goldberg, Jenna D.

Banerjee, Arnob

Usmani, Saad Zafar

机构：

[1] City Hope Natl Med Ctr, Comprehens Canc Ctr, Duarte, CA USA

[2] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[3] Hosp Clin Univ Salamanca, Salamanca, Spain

[4] Vrije Univ Amsterdam, Amsterdam Univ, Med Ctr, Amsterdam, Netherlands

[5] Karolinska Univ Hosp Huddinge, Stockholm, Sweden

[6] Clin Univ Navarra, CIMA, CIBERONC, IDISNA, Pamplona, Spain

[7] Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Barcelona, Spain

[8] Hosp Badalona Germans Trias & Pujol, Inst Josep Carreras, Barcelona, Spain

[9] Univ Barcelona, IDIBAPS Hosp Clin, Hematol Dept, Inst Hematol & Oncol, Barcelona, Spain

[10] Mt Sinai Sch Med, New York, NY USA

[11] Atrium Hlth, Levine Canc Inst, Charlotte, NC USA

[12] Ctr Hosp Lyon Sud, Serv Hematol Clin, Pierre Benite, France

[13] CHRU Tours, Hop Bretonneau, Serv Hematol & Therapie Cellulaire, Tours, France

[14] Janssen R&D, Raritan, NJ USA

[15] Janssen R&D, Spring House, PA USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期

关键词：

D O I：

10.1200/JCO.2021.39.15_suppl.8007

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

8007

引用

页数：5